3
Announcements
Trials
Browse
Landscape
Status
Completed
11
Recruiting
5
Terminated
2
Withdrawn
1
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Breast Neoplasms
14
Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Colorectal Neoplasms
9
Prostatic Neoplasms
8
Lung Neoplasms
7
Melanoma
6
Pancreatic Neoplasms
5
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplastic Cells, Circulating
4
Hematologic Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Glioblastoma
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
2
Sarcoma
2
Recurrence
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Liver Diseases
2
Kidney Neoplasms
2
Glioma
2
Fibrosis
2
Interventions
Dexamethasone
64
Cyclophosphamide
40
Bortezomib
37
Melphalan
24
Lenalidomide
23
Thalidomide
17
pomalidomide
16
fludarabine
12
daratumumab
11
carfilzomib
10
Filgrastim
8
Doxorubicin
8
Busulfan
6
Prednisone
5
Peripheral Blood Stem Cell Transplantation
5
Bendamustine Hydrochloride
5
selinexor
4
sargramostim
4
isatuximab
4
fludarabine phosphate
4
Surveys and Questionnaires
4
Etoposide
4
Clarithromycin
4
Calcium Dobesilate
4
liposomal doxorubicin
3
ixazomib
3
Radiotherapy
3
Neoadjuvant Therapy
3
Mycophenolic Acid
3
Methylprednisolone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Multiple Myeloma
×
Blood Specimen Collection
×
Clear all
NCT05735704
2025-03-26
SANGUINE
JaxBio Ltd
Unknown
3,000 enrolled